| Product | Indication | Preclinical | Phase One | Phase Two | Phase Three |
| Retinal Disease Programs | |||||
| KIO-301 (Intravitreal) | Retinitis Pigmentosa |
|
|
|
|
| Choroideremia |
|
|
|
|
|
| Stargardt Disease |
|
|
|
|
|
| KIO-104 (Intravitreal) | Posterior Non-Infectious Uveitis |
|
|
|
|
